Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (Europe)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (Europe)
The kindness of strangers : a gang of scary-looking youths stepped in to save me from being mugged
19/10/2025
US couples are moving in together sooner to save money : ‘The world isn’t made for singles’
19/10/2025
North Korean soldier defects to South Korea across heavily fortified border
19/10/2025
Shobana Jeyasingh Dance : We Caliban review – postcolonial take on The Tempest is difficult to pin down
19/10/2025
The blood pressure secret : everything you need to know to improve yours – and live a longer, healthier life
19/10/2025
Huey Morgan looks back : ‘My father left when I was seven. Music was a way to derail those feelings of not being good enough’
19/10/2025